Hydron;2-hydroxyethyl(trimethyl)azanium;2-hydroxypropane-1,2,3-tricarboxylate | 17159-56-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Hydron;2-hydroxyethyl(trimethyl)azanium;2-hydroxypropane-1,2,3-tricarboxylate
• 英文别名: hydron;2-hydroxyethyl(trimethyl)azanium;2-hydroxypropane-1,2,3-tricarboxylate
• CAS: 17159-56-7
• 化学式: C16H34N2O9
• 分子量: 398.45
• InChiKey: KGUWSYXISDXUCK-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  -5.77
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  181
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• Crystalline choline ascorbate
  申请人：——

  公开号：US20020161039A1

  公开（公告）日：2002-10-31

  Crystalline ascorbate, in particular choline ascorbate in the form of crystals free from water of crystallization, processes for its preparation, and its used are described.

  介绍了抗坏血酸晶体，特别是不含结晶水的晶体形式的抗坏血酸胆碱、其制备工艺和用途。
• Aqueous solutions for reducing the rate of oxygen loss, and methods thereof
  申请人：Instrumentation Laboratory Company

  公开号：US20040137633A1

  公开（公告）日：2004-07-15

  Compositions and methods for reducing the rate of loss of oxygen from a solution and increasing the effective life span of oxygen-containing calibration solutions.

  用于降低溶液中氧气的流失率和延长含氧校准溶液有效寿命的成分和方法。
• Choline ascorbate formulations
  申请人：Habich Andreas

  公开号：US20060153912A1

  公开（公告）日：2006-07-13

  The invention relates to novel choline ascorbate-containing formulations; processes for their preparation and their use in human or animal foods, or human or animal food supplements or pharmaceuticals.

  本发明涉及含有抗坏血酸胆碱的新型制剂；其制备工艺及其在人类或动物食品、人类或动物食品补充剂或药品中的用途。
• METHOD FOR REDUCING THE RATE OF OXYGEN LOSS FROM AQUEOUS SOLUTIONS
  申请人：Instrumentation Laboratory Company

  公开号：EP1527338B1

  公开（公告）日：2011-08-31
• COMPOSITIONS AND METHOD FOR REDUCING THE RATE OF OXYGEN LOSS FROM AQUEOUS
  申请人：Instrumentation Laboratory Company

  公开号：EP1527338A1

  公开（公告）日：2005-05-04